ArticleAnnals of surgical oncology2026
Breaking New Ground in Cervical Metastatic Carcinoma of Unknown Primary: Neoadjuvant Immunochemotherapy's Pathologic Regression and Survival Advantage.
Qiufeng Jin et al.PubMed ↗Publisher ↗
No numbers read from the abstract.